SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Young-onset dementia is more than twice as common as previously thought, study finds


A new study published in JAMA Neurology found that young-onset dementia—or dementia that occurs before the age of 65—may be more prevalent than previously believed, reports Judy George for MedPage Today.

Home- and community-based memory care models

Study details

In the study, the authors examined 95 studies published between January 1990 and March 2020 for a systematic review. Seventy-four of those studies—which together included 2,760,379 participants—were then included in a meta-analysis. The studies were primarily conducted in Europe and among older populations in Asia, North America, and Oceania.

Through the meta-analysis, the researchers estimated age-specific prevalence for dementia in five-year age intervals between the ages of 30 to 64. Results from each five-year age interval were then standardized using the World Health Organization (WHO) world standard population from 2000 to 2025, the U.S. standard population of 2000, and the European standard population from 2011 to 2020.

Findings

According to the researchers, the global age-standardized prevalence of young-onset dementia was 119 per 100,000 people, which corresponds to 3.9 million cases among people between the ages of 30 and 64 worldwide. Prevalence estimates ranged from 1.1 per 100,000 among people ages 30 to 34 to 77.4 per 100,000 among people ages 60 to 64.

According to the researchers, the global prevalence reported in the study is higher than two commonly referenced estimates, which were based on retrospective register-based studies. These previous studies showed a prevalence of 54 and 42.3 per 100,000 people.

Overall, the researchers found that highest-prevalence cause of young-onset dementia was Alzheimer's disease (41.1 per 100,000), followed by vascular dementia and frontotemporal dementia. However, prevalence for Alzheimer's disease was lower than the other two conditions until age 50.

The study also found that the age-standardized prevalence of young-onset dementia was 159.4 per 100,000 people in Europe—corresponding to around 500,000 cases—and 114.7 per 100,000 in the United States—corresponding to around 200,000 cases. The researchers said they attributed this difference primarily to differences in each population's ages, MedPage Today reports.

Findings likely 'an underestimation,' researchers say

The researchers said that while their findings indicated the prevalence of young-onset dementia "is higher than previously thought, it is probably an underestimation owing to lack of high-quality data."

The researchers cited several limitations of the study, including an underrepresentation of studies from Africa and low-income countries and the fact that 41 of the studies reported data only from patients ages 60 to 64. Additionally, some of the studies had small samples, and dementia diagnosis was not always defined or reported properly.

In an accompanying editorial, David Knopman, a physician at Mayo Clinic, wrote that dementia may be underdiagnosed at younger ages due to reliance on passive surveillance methods to identify cases. He wrote that using passive surveillance increases the odds of "undercounting or overcounting cases owing to misdiagnosis (e.g., young-onset dementia as a psychiatric disorder or vice versa) or of noncontact by the young patient with dementia with the medical system."

To improve the accuracy of future prevalence information, the study's authors recommended conducting more cohort studies and standardizing reporting procedures in prevalence studies.

Knopman also cited the "dramatic differences" between the prevalence and incidence of young-onset dementia and later-onset dementia. "Young-onset dementia is a particularly disheartening diagnosis because it affects individuals in their prime years, in the midst of their careers, and while raising families," he wrote. "Most dementia care is geared for older patients, and as a consequence, services are rarely available to address the needs of someone diagnosed with dementia in their 50s who has dependent children at home and a spouse who must continue working." (George, MedPage Today, 7/19)


Case profiles: Keep Alzheimer’s patients safe at home and in the community

The number of patients with Alzheimer’s and other dementias is projected to increase from 5.8 million to 14 million by the year 2050—amounting to an $800 billion annual cost to the U.S. health system. Patients live with dementia for an average of ten years, and require twice as many hospital stays as other older adults.

To manage this growing, complex population, providers need to invest now in support services that will keep dementia patients safe at home and in the community.


Neuroscience clinical technology compendium

Access the resource library

data

Download the compendium to learn about the latest technologies for neurology, cerebrovascular care, neurosurgery, and brain imaging.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.